Lachman Consultant Services, Inc. is proud to announce its participation in the 11th Global Pharmaceutical Quality Summit (GPQS), hosted by the Indian Pharmaceutical Alliance (IPA) — one of the premier global forums for advancing pharmaceutical quality, regulatory excellence, and operational innovation.

The Summit will take place over two days, bringing together industry leaders, regulators, experts from academia, and global quality professionals for focused dialogue on the future of pharmaceutical quality. Participants will explore emerging trends across talent transformation, technology adoption, AI-enabled quality systems, and strategies for regulatory alignment in increasingly complex global markets. Visit the event website here for more information: 11th Global Pharmaceutical Quality Summit Event 2026

Lachman Leadership Representing at GPQS

We are honored that Fran Zipp, President & CEO, and John Darby, Executive Director, will be attending the Summit as representatives of Lachman Consultants. Their participation underscores our firm’s ongoing commitment to thought leadership, quality excellence, and collaboration with global stakeholders shaping the future of pharmaceutical operations.

Their engagement in this year’s Summit will include attending high-impact sessions, participating in strategic dialogues with industry and regulatory leaders, and contributing to discussions on strengthening global quality culture and compliance frameworks.

Fran Zipp and John Darby are also open for 1-to-1 meetings regarding how Lachman can assist your company during their time on site. Please reach out to us here to schedule your meeting.

Why This Summit Matters

The Global Pharmaceutical Quality Summit is recognized as a focal platform for advancing quality practices across the pharmaceutical value chain. It attracts hundreds of senior leaders and dozens of global experts from government agencies, regulatory bodies like the US FDA, EDQM, MHRA, and CDSCO, and from industry and academia.

Key themes for the 11th edition include:

  • Leveraging digital and AI-driven quality systems
  • Developing talent for tomorrow’s quality challenges
  • Enhancing operational maturity across the global pharma ecosystem
  • CEO-level perspectives on shared industry vision and quality leadership

 

This event also marks the launch of the IPA Awards, recognizing outstanding academic contributions that advance pharmaceutical quality standards in India and beyond — reinforcing the Summit’s role in driving innovation, collaboration, and long-term quality excellence.

Looking Ahead

Lachman Consultants remains deeply invested in supporting the industry’s evolution toward robust, forward-looking quality systems that not only ensure compliance but also enhance patient safety and global trust in pharmaceutical products. We look forward to sharing key insights and outcomes from this year’s Summit as the event unfolds.

Stay tuned for updates from GPQS 2026 and reflections from this important event.